Abh Healthcare Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of ABH Healthcare Ltd is ₹ 42 as of 30 Oct 15:30 . The P/E Ratio of ABH Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of ABH Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of ABH Healthcare Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The ebitda of ABH Healthcare Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The net profit of ABH Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The Dividend Payout of ABH Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About ABH Healthcare Ltd

ABH Healthcare Limited was originally incorporated as a private limited company in the name and style of 'ABH Healthcare Private Limited' vide certificate of incorporation dated March 2, 2021 issued by Registrar of Companies, Central Registration Centre.
Further, Company acquired the sole Proprietorship Concern of Dr. Kamal Baghi, our Promoter in the name 'Anil Baghi Hospital' via Business Transfer Agreement dated March 16, 2022.
Subsequently, it was converted from a private Company to a public Company and the name was changed to 'ABH Healthcare Limited', and a fresh Certificate of incorporation dated November 15, 2024 was issued by the Registrar of Companies, Chandigarh. The Company operate hospital under the 'Anil Baghi Hospital' brand, honoring the sacrifice of late Shri Anil Baghi.
Located in Ferozepur, Punjab, hospital has a capacity of 150 beds.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5,778scientists and its state-of-the-art facilities, spread over 3 million sq. ft.
The Company operate into 4 business divisions comprising of Discovery Services, Translational & Clinical Research, Dedicated Centers, and Contract Development and Manufacturing Services. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of null and Syngene International Ltd

Which company has a larger market capitalization, ABH Healthcare Ltd or Syngene International Ltd?

Market cap of ABH Healthcare Ltd is 48 Cr while Market cap of Syngene International Ltd is 16,251 Cr

What are the key factors driving the stock performance of ABH Healthcare Ltd and Syngene International Ltd?

The stock performance of ABH Healthcare Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ABH Healthcare Ltd and Syngene International Ltd?

As of October 31, 2026, the ABH Healthcare Ltd stock price is INR ₹42.0. On the other hand, Syngene International Ltd stock price is INR ₹402.6.

How do dividend payouts of ABH Healthcare Ltd and Syngene International Ltd compare?

To compare the dividend payouts of ABH Healthcare Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.